Reduced levels of N'-methyl-2-pyridone-5-carboxamide and lysophosphatidylcholine 16:0 in the serum of patients with intrahepatic cholangiocarcinoma, and the correlation with recurrence-free survival.
about
Reduced levels of N'-methyl-2-pyridone-5-carboxamide and lysophosphatidylcholine 16:0 in the serum of patients with intrahepatic cholangiocarcinoma, and the correlation with recurrence-free survival.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Reduced levels of N'-methyl-2- ...... with recurrence-free survival.
@en
Reduced levels of N'-methyl-2- ...... with recurrence-free survival.
@nl
type
label
Reduced levels of N'-methyl-2- ...... with recurrence-free survival.
@en
Reduced levels of N'-methyl-2- ...... with recurrence-free survival.
@nl
prefLabel
Reduced levels of N'-methyl-2- ...... with recurrence-free survival.
@en
Reduced levels of N'-methyl-2- ...... with recurrence-free survival.
@nl
P2093
P2860
P356
P1433
P1476
Reduced levels of N'-methyl-2- ...... with recurrence-free survival.
@en
P2093
Boram Park
Byong Chul Yoo
Eun Kyung Hong
Jungnam Joo
Sang Myung Woo
Sang-Jae Park
Sung-Sik Han
Woo Jin Lee
P2860
P304
112598-112609
P356
10.18632/ONCOTARGET.22607
P407
P577
2017-11-22T00:00:00Z